Pyoderma - 36 Studies Found
Withdrawn |
: Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum : Pyoderma Gangrenosum : 2008-06-02 : Drug: adalimumab 40 mg weekly adalimumab injection. |
Completed |
: Prevalence of RHD, Pyoderma and Scabies in Children in Fiji : Streptococcus Group A : 2006-01-30 |
Completed |
: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease :
|
Completed |
: Incidence of Group A Strep Pharyngitis in School Children in Fiji : Streptococcus Group A : 2006-01-30 |
Recruiting |
: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases :
|
Recruiting |
: A Real World, Observational Registry of Chronic Wounds and Ulcers :
: Other: Usual care advanced dressings, off-loading, venous ulcer compression, arterial screening |
Completed |
: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease : Crohn Disease : 2010-11-02 : Drug: Tacrolimus Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week o |
Completed |
: A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum : Pyoderma Gangrenosum : 2013-10-15 : Biological: Xilonix IV |